These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9343252)

  • 1. A second form of infectious bursal disease virus-associated tubule contains VP4.
    Granzow H; Birghan C; Mettenleiter TC; Beyer J; Köllner B; Mundt E
    J Virol; 1997 Nov; 71(11):8879-85. PubMed ID: 9343252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA-Binding Protein of a Double-Stranded RNA Virus Acts like a Scaffold Protein.
    Mata CP; Mertens J; Fontana J; Luque D; Allende-Ballestero C; Reguera D; Trus BL; Steven AC; Carrascosa JL; Castón JR
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to VP4 protein is an indicator discriminating pathogenic and nonpathogenic IBDV infection.
    Wang Y; Wu X; Li H; Wu Y; Shi L; Zheng X; Luo M; Yan Y; Zhou J
    Mol Immunol; 2009 Jun; 46(10):1964-9. PubMed ID: 19361862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The last C-terminal residue of VP3, glutamic acid 257, controls capsid assembly of infectious bursal disease virus.
    Chevalier C; Lepault J; Da Costa B; Delmas B
    J Virol; 2004 Apr; 78(7):3296-303. PubMed ID: 15016850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophilin A Interacts with Viral VP4 and Inhibits the Replication of Infectious Bursal Disease Virus.
    Wang N; Zhang L; Chen Y; Lu Z; Gao L; Wang Y; Gao Y; Gao H; Cui H; Li K; Liu C; Zhang Y; Qi X; Wang X
    Biomed Res Int; 2015; 2015():719454. PubMed ID: 26090438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Ser-652 and Lys-692 in the protease activity of infectious bursal disease virus VP4 and identification of its substrate cleavage sites.
    Lejal N; Da Costa B; Huet JC; Delmas B
    J Gen Virol; 2000 Apr; 81(Pt 4):983-92. PubMed ID: 10725424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of MOI ratio on the composition and yield of chimeric infectious bursal disease virus-like particles by baculovirus co-infection: deterministic predictions and experimental results.
    Hu YC; Bentley WE
    Biotechnol Bioeng; 2001 Oct; 75(1):104-19. PubMed ID: 11536133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-step RT-PCR for the detection of infectious bursal disease virus in clinical samples.
    Kataria RS; Tiwari AK; Nanthakumar T; Goswami PP
    Vet Res Commun; 2001 Jul; 25(5):429-36. PubMed ID: 11469514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic structure analysis of VP3 of infectious bursal disease virus.
    Deng X; Gao Y; Gao H; Qi X; Cheng Y; Wang X; Wang X
    Virus Res; 2007 Oct; 129(1):35-42. PubMed ID: 17590471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endopeptidase activity characterization of E. coli-derived infectious bursal disease virus protein 4 tubules.
    Chang GR; Wang MY; Liao JH; Hsiao YP; Lai SY
    Protein Eng Des Sel; 2012 Nov; 25(11):789-95. PubMed ID: 23081839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different architectures in the assembly of infectious bursal disease virus capsid proteins expressed in insect cells.
    Martinez-Torrecuadrada JL; Castón JR; Castro M; Carrascosa JL; Rodriguez JF; Casal JI
    Virology; 2000 Dec; 278(2):322-31. PubMed ID: 11118356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic and immunogenic properties of baculovirus-expressed infectious bursal disease viral proteins.
    Dybing JK; Jackwood DJ
    Avian Dis; 1998; 42(1):80-91. PubMed ID: 9533084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
    Ludert JE; Ruiz MC; Hidalgo C; Liprandi F
    J Virol; 2002 Jul; 76(13):6643-51. PubMed ID: 12050377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines.
    Martinez-Torrecuadrada JL; Saubi N; Pagès-Manté A; Castón JR; Espuña E; Casal JI
    Vaccine; 2003 Jul; 21(23):3342-50. PubMed ID: 12804866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four infectious bursal disease viruses isolated from different bird species.
    Wang YS; Wang ZC; Tang YD; Shi ZL; He KW; Li Y; Hou JB; Yao HC; Fan HJ; Lu CP
    Arch Virol; 2007; 152(10):1787-97. PubMed ID: 17619114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The maturation process of pVP2 requires assembly of infectious bursal disease virus capsids.
    Chevalier C; Lepault J; Erk I; Da Costa B; Delmas B
    J Virol; 2002 Mar; 76(5):2384-92. PubMed ID: 11836416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope.
    Chen DY; Estes MK; Ramig RF
    J Virol; 1992 Jan; 66(1):432-9. PubMed ID: 1370090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines.
    Martinez-Torrecuadrada JL; Saubi N; Pagès-Manté A; Castón JR; Espuña E; Casal JI
    Vaccine; 2003 May; 21(17-18):1952-60. PubMed ID: 12706682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus.
    Brandt M; Yao K; Liu M; Heckert RA; Vakharia VN
    J Virol; 2001 Dec; 75(24):11974-82. PubMed ID: 11711587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.